New generics boost CVS Caremark’s 1Q profit
The influx of new generic drugs hoisted earnings above Wall Street’s forecast but tempered sales growth in the first quarter at CVS Caremark Corp. CVS said Wednesay that for the three months ended March 31, income from continuing operations attributable to CVS Caremark surged 23.